Direct ex vivo measurement of CD8+ T-lymphocyte responses to human parvovirus B19

Journal of Virology

Volumn 75, Issue 1, 2001, Pages 540-543

  Tolfvenstam, T ^a   Oxenius, A ^a   Price, D A ^a   Shacklett, B L ^a   Spiegel, H M L ^a   Hedman, K ^a   Norbeck, O ^a   Levi, M ^a   Olsen, K ^a   Kantzanou, M ^a   Nixon, D F ^a   Broliden, K ^a   Klenerman, P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B35 ANTIGEN; VIRUS PROTEIN;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOGENICITY; PARVOVIRUS; PRIORITY JOURNAL; RESTRICTION MAPPING; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION;

ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; HLA-B35 ANTIGEN; HUMANS; PARVOVIRUS B19, HUMAN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0034751163     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.1.540-543.2001     Document Type: Article

References (35)

1. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: A case for historical reasoning
2. Human parvoviruses
3. Experimental parvoviral infection in humans
4. Persistence of B19 parvovirus in pediatric malignancies
5. Erythrocyte P antigen: Cellular receptor for B19 parvovirus
6. Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers
7. Direct visualisation of antigen specific CD8+ T cells during the primary immune response to EBV in vivo
8. Use of parvovirus-like particles for vaccination and induction of multiple immune responses
9. Parvovirus-like particles as vaccine vectors
10. Low level persistence of LCMV in immunocompetent mice
11. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients
12. CD8+ T-cell memory to viruses
13. Chronic parvovirus infection in a presumably immunologically healthy woman
14. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS
15. Virus-specific CD8+ T-cell memory determined by clonal burst size
16. Role of human parvovirus B19 in the pathogenesis of rheumatoid arthritis
17. Identification of a novel HLA A-25 restricted epitope in a conserved region of p24 gag (positions 71-80)
18. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
19. Rapid effector function in CD8+ memory T cells
20. Analysis of successful immune responses in persons infected with hepatitis C virus
21. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant
22. Clinical and laboratory findings in immunocompetent patients with persistent parvovirus B19 DNA in bone marrow
23. Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders
24. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides
25. Quantitation of HIV-1 specific CTL and plasma load of HIV-1
26. Parvovirus B19: Twenty-five years in perspective
27. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity
28. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19
29. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
30. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19
31. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis
32. Lymphoproliferative responses after infection with human parvovirus B19
33. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
34. Immunology taught by viruses
35. 51Cr-release assay?